Related Experiment Video
Updated: Jul 17, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Defining optimal therapy for muscle invasive bladder cancer
Harry W Herr1, Zohar Dotan, S Machele Donat
1Department of Urology and Genitourinary Oncology Service, Division of Solid Tumor Oncology, Memorial Sloan-Kettering Cancer Center, Cornell University Weill Medical College, New York, New York 10021, USA. herrh@mskcc.org
The optimal treatment for muscle invasive bladder cancer involves neoadjuvant chemotherapy before radical cystectomy with pelvic lymph node dissection. This strategy improves survival compared to surgery alone.
Area of Science:
- Uro-oncology
- Surgical oncology
- Medical oncology
Background:
- Muscle invasive bladder cancer (MIBC) requires aggressive treatment strategies.
- Optimizing curative therapy delivery is crucial for patient survival.
Purpose of the Study:
- To define the optimal curative strategy for muscle invasive bladder cancer.
- To determine the best approach for delivering curative therapy for MIBC.
Main Methods:
- Systematic review of published reports from 1985 to 2006.
- Analysis of cohort, phase II, and randomized phase III studies (Level 1-3 evidence).
- Focus on treatments for muscle invasive bladder cancer (T2-T4a stage).
Main Results:
- Cisplatin-based chemotherapy combined with radical cystectomy and pelvic lymph node dissection significantly improves survival.
- High-quality surgery is a critical predictor of survival, even with chemotherapy.
- Neoadjuvant chemotherapy is preferred over adjuvant chemotherapy due to better tolerance and completion rates.
Conclusions:
- Neoadjuvant chemotherapy followed by radical cystectomy and complete pelvic lymph node dissection represents the optimal curative strategy for most MIBC patients.
- This combined approach offers superior survival outcomes for muscle invasive bladder cancer.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Urinary Tract Infection IV: Nursing Management
Tumor Immunotherapy
Urinary Tract Calculi III: Medical Management
Urinary Tract Calculi VI: Surgical Management
